Charles Stacey, MBBS, MBA
• President and CEO, Cerecin
• Member of Board of Governors, Accreditation Council for Medical Affairs
Dr. Stacey has over 20 years of experience in healthcare working as a provider, entrepreneur and investor. He is now leading Cerecin, a biotech company with a focus on brain health, in the fight against Alzheimer's and other neurological diseases.
Prior to joining Cerecin, Dr. Stacey was with Inventages, a global healthcare venture capital and private equity group with $1.5 billion under management. Before that, Dr. Stacey co-founded a medical device company to develop a product that he invented through the course of his clinical work as a trauma surgeon.
Earlier in his career, Dr. Stacey worked as an orthopaedic and reconstructive surgeon in London specializing in lower limb and hand surgery.
Dr. Stacey is a member of Board of Governors for the Accreditation Council for Medical Affairs, a self-governing, independent organization which promotes standards of excellence around both core technical competencies and ethical practices for pharmaceutical industry professionals in medical affairs.
Dr. Stacey founded Alzheimer's Association Business Consortium (AABC) in 2015 in the US, with the mission to support the advancement of Alzheimer’s disease research and innovation in small companies.
Dr. Stacey received his medical degree from King's College London and practiced as a trauma and reconstructive surgeon. His undergraduate degree and research were in the neurosciences at University of College London. Dr. Stacey also completed an MBA at the London Business School and the Wharton School.